Centre for Policy on Ageing
 

 

Cost of Alzheimer's disease in a developing country setting
Author(s)M Zencir, N Kuzu, N Gördeles Beser
Journal titleInternational Journal of Geriatric Psychiatry, vol 20, no 7, July 2005
Pagespp 616-622
Sourcehttp://www.interscience.wiley.com
KeywordsDementia ; Costs [care] ; Econometrics ; Turkey ; Developing countries.
AnnotationAn observational study was conducted with 42 Alzheimer's disease (AD) patients and their primary caregivers in Denizli, Turkey. During initial interviews, demographic data and medical histories were collected with questionnaires. For an observational period of 15 days, data on time spent for patient care were collected, using standard forms. Calculations on direct costs (e.g. per day medication, outpatient physician visit in the past 3 months), indirect costs (e.g. time spent for care by caregiver for daily living - ADL), and instrumental activity (IADL) were made by summing and taking averages of the appropriate items. ANOVA and linear regressions were the methods for comparisons. Patients' primary caregivers were mainly their children and/or spouses. For severely damaged cognition, the maximum and mean times spent (per week) were 21 hours and 17.5 hours. The average annual cost per case was the most significant item in the overall cost, and it showed an increase with the declining function of patients. Daily medication cost reflected the same pattern. In contrast, cost of outpatient physician was the lowest among the patients with the worst cognition. This pilot study thus gives an idea of the cost of AD in developing countries where determining the actual cost can be difficult. (RH).
Accession NumberCPA-050906209 A
ClassmarkEA: QDC: WE: 7GB: 7B

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk